Cosmos Health Sees C-Sept PRO Monthly Sales Exceed $108K, Annualized $1.3M
COSM•Cosmos Health’s C-Sept PRO averaged $93,000 monthly sales over six months and $108,000 monthly in the past three months, projecting over $1.3 million in annualized revenue. Adoption by leading Greek public and private hospital groups and repeat orders are delivering roughly $0.9 million in gross profit at a 72% margin.
1. Sales Trajectory
Over the past six months, C-Sept PRO posted average monthly sales exceeding $93,000, accelerating to more than $108,000 in the last three months and projecting annualized revenue above $1.3 million.
2. Margin and Profitability
With gross margins of approximately 72%, the product is on track to generate around $0.9 million in annualized gross profit, driven by repeat ordering and participation in public hospital tenders.
3. Expansion Strategy
Cosmos Health plans to leverage Cana Laboratories’ European GMP-certified manufacturing and its existing distribution network to extend its hospital-focused antiseptics business into additional European markets.
